|10000HB4707sam001||- 2 -||LRB100 16559 RLC 40430 a|
that purpose authorizing the Department of Financial and
Professional Regulation to license and discipline these health
(5) A legislative Task Force is necessary to study
prescription opioid abuse, and to make recommendations of
future legislation to address this issue.
Prescription Drug Task Force.
(a) The Prescription Drug Task Force is created. The Task
Force shall be composed of 25 members appointed as follows:
(1) one member of the House of Representatives
appointed by the Speaker of the House of Representatives;
(2) one member of the House of Representatives
appointed by the Minority Leader of the House of
(3) one member of the Senate appointed by the President
of the Senate;
(4) one member of the Senate appointed by the Minority
Leader of the Senate;
(5) the Secretary of Human Services or his or her
(6) one member from each of the following organizations
appointed by the Secretary of Human Services from nominees
made by the respective organization:
(A) a statewide organization representing advanced
practice registered nurses;
|10000HB4707sam001||- 3 -||LRB100 16559 RLC 40430 a|
(B) a statewide organization representing
(C) a statewide organization representing retail
(D) a statewide organization representing
(E) a statewide organization representing
(F) a statewide organization representing
(G) a statewide organization representing
(H) a statewide organization representing
(I) a statewide organization representing
(7) 2 members who are parents whose children have died
from drug overdoses, appointed by the Secretary of Human
(8) 2 members who are selected from county sheriffs,
municipal police chiefs, and State's Attorneys, appointed
by the Attorney General;
(9) one member who is a peace officer specializing in
the enforcement of laws prohibiting the illegal
manufacture, delivery, and possession of controlled
substances and methamphetamine, appointed by the Director
|10000HB4707sam001||- 4 -||LRB100 16559 RLC 40430 a|
of State Police;
(10) 2 members who are representatives of providers of
addiction treatment services, appointed by the Secretary
of Human Services;
(11) 2 members who are public defenders, appointed by
the Attorney General; and
(12) 2 members who are physicians licensed to practice
medicine in all its branches, including one physician
specializing in pain management and one physician
specializing in emergency medicine, nominated by a
statewide organization representing physicians licensed to
practice medicine in all its branches, appointed by the
Secretary of Human Services.
(b) The Task Force shall choose its chairperson from among
its members and any other officers it deems appropriate.
(c) The Task Force shall initially meet within 30 days
after the effective date of this Act. The members of the Task
Force shall receive no compensation for their services as
members of the Task Force but may be reimbursed for expenses
from appropriations made by law.
(d) The Task Force may seek the assistance of the
Departments of Financial and Professional Regulation and
Public Health in performing its duties.
(e) The Task Force shall:
(1) study prescription opioid abuse in this State;
(2) study the over-prescription of opioids such as
|10000HB4707sam001||- 5 -||LRB100 16559 RLC 40430 a|
Hydrocodone and Oxycodone; and
(3) recommend any legislation, including amendments to
the Illinois Controlled Substances Act, that would have the
effect of reducing opioid addiction and abuse.
(f) The Task Force shall focus its efforts in a manner that
best utilizes the unique skills and perspectives of the experts
on the Task Force.
(g) The Task Force shall submit a report of its
recommendations to the General Assembly on or before December
31, 2019. The report to the General Assembly shall be filed
with the Clerk of the House of Representatives and the
Secretary of the Senate in electronic form only, in the manner
that the Clerk and the Secretary shall direct.
(h) The Department of Human Services shall provide
administrative and other support to the Task Force.
(i) This Act is repealed on January 1, 2021.
This Act takes effect upon